"As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
Administration, Oral
Aged
Anticoagulants
/ administration & dosage
Atrial Fibrillation
/ complications
Catheter Ablation
/ adverse effects
Clinical Decision-Making
Drug Administration Schedule
Feasibility Studies
Female
Heart Rate
/ drug effects
Humans
Male
Middle Aged
Patient Compliance
Patient Preference
Patient Selection
Recurrence
Risk Assessment
Risk Factors
Stroke
/ diagnosis
Time Factors
Treatment Outcome
atrial fibrillation
atrial fibrillation ablation
nonvitamin K antagonist oral anticoagulants
stroke prevention
thromboembolism
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
25
11
2018
revised:
13
01
2019
accepted:
13
01
2019
pubmed:
2
2
2019
medline:
20
8
2020
entrez:
2
2
2019
Statut:
ppublish
Résumé
After atrial fibrillation (AF) ablation, oral anticoagulation (OAC) is recommended if stroke risk as assessed by CHA We identified 99 patients (84% male, age 64 ± 8 years), CHA The use of as needed NOACs when AF is suspected with pulse monitoring is effective and safe to maintain low risk of stroke and bleeding after successful ablation. Transition back to daily NOAC use should be anticipated in about one quarter of patients.
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-638Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 Wiley Periodicals, Inc.